Johnson & Johnson News Headlines

JNJ 
$107.88
*  
0.11
0.1%
Get JNJ Alerts
*Delayed - data as of Sep. 22, 2014  -  Find a broker to begin trading JNJ now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    JNJ Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Dividends Vs. Capital Appreciation: Wrong Question
9/22/2014 10:14:00 PM - Seeking Alpha

Novo Nordisk Reveals Fresh Data on Xultophy for Diabetes - Analyst Blog
9/22/2014 6:20:00 PM - Zacks.com

Glaxo Fined Roughly $484M in China Bribery Probe - Analyst Blog
9/22/2014 5:45:00 PM - Zacks.com

Novartis' (NVS) Data on Anti-Cancer Drug LBH589 Published - Analyst Blog
9/22/2014 4:45:00 PM - Zacks.com

Flexion Continues to Fall Post Clinical Hold on FX006 - Analyst Blog
9/22/2014 3:59:00 PM - Zacks.com

Surprising Silver Lining for Gilead Sciences, inc. Stock
9/22/2014 3:37:02 PM - Motley Fool

Is the Stock Market Ready to Plunge? Here Are 3 Things to Do Right Now
9/22/2014 2:16:02 PM - Motley Fool

Double Your Passive Income With This Dividend Investment Strategy
9/22/2014 11:26:01 AM - VectorVest

The Point Of No (Negative) Return
9/21/2014 7:00:00 AM - Seeking Alpha

3 Ways to Outperform the Market with Quality ETFs - ETF News And Commentary
9/19/2014 2:00:01 PM - Zacks.com

XLV, JNJ, AMGN, BMY: ETF Inflow Alert
9/19/2014 11:00:14 AM - BNK Invest

3 Best Stocks to Invest in Pharma
9/19/2014 9:13:02 AM - Motley Fool

Why You Should Sell Bristol-Myers Squibb And Buy Johnson & Johnson Instead
9/19/2014 8:43:00 AM - Seeking Alpha

Head-To-Head Comparison: Pfizer Vs. Johnson & Johnson On Environmental Metrics
9/18/2014 3:49:00 PM - Seeking Alpha

Retired Investors Should Not Fear Recessions Or A Bad Market: Part 1
9/18/2014 11:13:00 AM - Seeking Alpha

Gilead Sciences, inc. Stock's Incoming Game Changer
9/18/2014 8:45:02 AM - Motley Fool

Don't Own A Company If You Wouldn't Display It On Your Wall
9/17/2014 11:11:00 PM - Seeking Alpha

3 Hot Ways to Play the Biotechnology Bonanza
9/17/2014 10:52:17 AM - InvestorPlace Media

New Active ETF for All Risk Environments
9/17/2014 10:05:47 AM - Benzinga

Actavis Is The Best Bet In The Drug Sector
9/17/2014 9:35:00 AM - Seeking Alpha

Johnson & Johnson: Slow And Steady Core Holding, But No Discount Here
9/17/2014 5:07:00 AM - Seeking Alpha

Buy The Dip In Gilead: Why A Decrease In Quarterly Sovaldi Revenue Is Expected
9/16/2014 12:31:00 PM - Seeking Alpha

Peregrine Pharmaceuticals Inc. (PPHMP) Ex-Dividend Date Scheduled for September 17, 2014
9/16/2014 9:00:02 AM - NASDAQ.com News

Is There Further Upside In Medivation?
9/16/2014 8:27:00 AM - Seeking Alpha

Tokai Pharmaceuticals IPO: Lack Of Product Diversity Should Leave Investors Cautious
9/15/2014 8:41:00 AM - Seeking Alpha